Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB

NCT01953783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Lymphoma

Interventions

DRUG: IXAZOMIB

Sponsor

Millennium Pharmaceuticals, Inc.